A living biobank of breast cancer organoids captures disease heterogeneity

Sachs, Norman, de Ligt, Joep, Kopper, Oded, Gogola, Ewa, Bounova, Gergana, Weeber, Fleur, Balgobind, Anjali Vanita, Wind, Karin +23 more·2018·Cell

Cited by (1,002)

Items 601–700 of 1,002

  1. Environmental exposures, stem cells, and cancer
    Tasha Thong, Chanese A. Forté, Evan M. Hill, Justin A. Colacino · 2019 · Pharmacology & Therapeutics
  2. Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision Medicine
    Hella Anna Bolck, Chantal Pauli, Elisabeth Göbel, Katharina Mühlbauer, Susanne Dettwiler, Holger Moch, Peter Schraml · 2019 · Frontiers in Cell and Developmental Biology
  3. FKBP4 is a malignant indicator in luminal A subtype of breast cancer
    Hanchu Xiong, Zihan Chen, Wenwen Zheng et al. · 2020 · Journal of Cancer
  4. Microfluidic droplets as structural templates for Matrigel to enable 1-week large organoid modeling
    Weijie Zhang, Donghui Li, Shengwei Jiang, Edgar A. Galan, Zhongyue Zhang, Laiqiang Huang, Shaohua Ma · 2021 · Chemical Engineering Science
  5. Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
    Matthew L. Tan, Ling Lu, Claudia Fischbach · 2021 · Advanced Drug Delivery Reviews
  6. CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression
    Mengna Zhang, Lingxian Zhang, Ajun Geng, Xiao Li, Yu Zhou, Liming Xu, Yi Arial Zeng, Jinpeng Li, Cheguo Cai · 2022 · Cell Reports
  7. Three-Dimensional in Vitro Models: A Promising Tool To Scale-Up Breast Cancer Research
    Vajiheh Azimian, Laleh Rafiee, Mohammadali Sheikholeslam, Laleh Shariati, Golnaz Vaseghi, Houman Savoji, Shaghayegh Haghjooy Javanmard · 2022 · ACS Biomaterials Science & Engineering
  8. Generation of Human Embryonic Stem Cell-Derived Lung Organoids for Modeling Infection and Replication Differences between Human Adenovirus Types 3 and 55 and Evaluating Potential Antiviral Drugs
    Shanshan Zhao, Xiaowei Wu, Zhihong Tan, Yi Ren, Lian Li, Junxian Ou, Ying Lin, Hongbin Song, Liqiang Feng, Donald Seto et al. · 2023 · Journal of Virology
  9. Organoids as preclinical models of human disease: progress and applications
    Baodan Chen, Cijie Du, Mengfei Wang, Jingyi Guo, Xingguo Liu · 2024 · Medical Review
  10. Patient‐Derived Tumor Organoids Combined with Function‐Associated ScRNA‐Seq for Dissecting the Local Immune Response of Lung Cancer
    Chang Liu, Kaiyi Li, Xizhao Sui, Tian Zhao, Ting Zhang, Zhongyao Chen, Hainan Wu, Chao Richard Li, Hao Li, Fan Yang et al. · 2024 · Advanced Science
  11. Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids
    Ruixin Yang, Wingyan Kwan, Yutong Du, Ranlin Yan, Lu Zang, Chen Li, Zhenggang Zhu, Io Hong Cheong, Zisis Kozlakidis, Yingyan Yu · 2024 · Cancer Letters
  12. Novel research model for in vitro immunotherapy: co-culturing tumor organoids with peripheral blood mononuclear cells
    Peng Li, Minli Huang, Yifan Ma, Yongbin Zhang, Changhong Shi · 2024 · Cancer Cell International
  13. Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine
    Breanna Mann, Nichole Artz, Rami Darawsheh, David E. Kram, Shawn Hingtgen, Andrew Satterlee · 2025 · npj Precision Oncology
  14. Clinical Implementation of Precision Medicine in Gastric Cancer
    Jaewook Jeon, Jae‐Ho Cheong · 2019 · Journal of the Korean Gastric Cancer Association
  15. Acetylation of ezrin regulates membrane–cytoskeleton interaction underlying CCL18-elicited cell migration
    Xiaoyu Song, Wanjuan Wang, Haowei Wang et al. · 2019 · Journal of Molecular Cell Biology
  16. A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer
    Xin Hua, Fangfang Duan, Wenyu Zhai, Chenge Song, Chang Jiang, Li Wang, Jiajia Huang, Huanxin Lin, Zhongyu Yuan · 2022 · Journal of Inflammation Research
  17. Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51
    Alice Turdo, Miriam Gaggianesi, Simone Di Franco, Veronica Veschi, Caterina D’Accardo, Gaetana Porcelli, Melania Lo Iacono, Irene Pillitteri, Francesco Verona, Gabriella Militello et al. · 2022 · Oncogene
  18. Metabolic Studies in Organoids: Current Applications, Opportunities and Challenges
    Elena Richiardone, Valentin Van den Bossche, Cyril Corbet · 2022 · Organoids
  19. Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors
    Siyu Zhou, Jinghan Lu, Shiyang Liu, Jiaqi Shao, Zhanwei Liu, Jianjun Li, Wan’an Xiao · 2023 · Frontiers in Cell and Developmental Biology
  20. Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer
    Wenting Peng, Xi Jin, Xiao‐En Xu, Yun‐Song Yang, Ding Ma, Zhi‐Ming Shao, Yi‐Zhou Jiang · 2023 · Cancer Research
  21. Using Biosensors to Study Organoids, Spheroids and Organs-on-a-Chip: A Mechanobiology Perspective
    Muhammad Sulaiman Yousafzai, John A. Hammer · 2023 · Biosensors
  22. Organoid Models of Cancer Explode with Possibilities
    Senthil K. Muthuswamy · 2018 · Cell stem cell
  23. Models of renal cell carcinoma used to investigate molecular mechanisms and develop new therapeutics
    Shapiro, Daniel D., Virumbrales-Muñoz, Maria, Beebe, David J., Abel, E. Jason · 2022 · Frontiers in Oncology
  24. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
    Jessica Kalla, Janette Pfneissl, Theresia Mair, Loan Tran, Gerda Egger · 2024 · Cellular Oncology
  25. The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
    Liuyue Kan, Yingyan Yu, Yaxue Wang, Lei Shi, Tingyuan Fan, Hui Chen, Chuanli Ren · 2025 · Molecular Cancer
  26. Label-free redox imaging of patient-derived organoids using selective plane illumination microscopy
    Peter F. Favreau, Jiaye He, Daniel A. Gil, Dustin A. Deming, Jan Huisken, Melissa C. Skala · 2020 · Biomedical Optics Express
  27. Progress in the application of organoids to breast cancer research
    Liping Yang, Baoer Liu, Haodong Chen, Rui Chang Gao, Kanghua Huang, Qiuyi Guo, Feng Li, Weicai Chen, Jinsong He · 2020 · Journal of Cellular and Molecular Medicine
  28. Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers
    Martin Liptay, Joana S. Barbosa, Sven Rottenberg · 2020 · Frontiers in Oncology
  29. Engineered models of tumor metastasis with immune cell contributions
    Pamela L. Graney, Daniel Naveed Tavakol, Alan G. Chramiec, Kacey Ronaldson-Bouchard, Gordana Vunjak‐Novakovic · 2021 · iScience
  30. Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety.
    Gerardo Botti, Maurizio Di Bonito, Monica Cantile · 2021 · PubMed Central
  31. Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
    Koji Miyabayashi, Hayato Nakagawa, Kazuhiko Koike · 2021 · Frontiers in Oncology
  32. Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma
    Thomas J. DePalma, Hemamylammal Sivakumar, Aleksander Skardal · 2021 · Advanced Drug Delivery Reviews
  33. Human lung organoid: Models for respiratory biology and diseases
    Wenhao Yang, Yingna Li, Fang Shi, Hanmin Liu · 2022 · Developmental Biology
  34. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer
    Silvia De Siervi, Cristian Turato · 2023 · International Journal of Molecular Sciences
  35. Patient-derived organoids: a promising tool for breast cancer research
    Yixin Shi, Zhanwen Guan, Gengxi Cai, Yichu Nie, Chuling Zhang, Wei Luo, Jia Liu · 2024 · Frontiers in Oncology
  36. High-throughput solutions in tumor organoids: from culture to drug screening
    Jianing Zuo, Yanhua Fang, Ruoyu Wang, Shanshan Liang · 2024 · Stem Cells
  37. Advances in the Development and Application of Human Organoids: Techniques, Applications, and Future Perspectives
    Zhangcheng Zhu, Yiwen Cheng, Xia Liu, Wenwen Ding, Jiaming Liu, Zongxin Ling, Lingbin Wu · 2025 · Cell Transplantation
  38. Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers
    Romario Nguyen, Sarah Da Won Bae, Gang Zhou, Scott A. Read, Golo Ahlenstiel, Jacob George, Liang Qiao · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  39. Trends in the development of human stem cell-based non-animal drug testing models
    Su-Jin Lee, Hyang‐Ae Lee · 2020 · Korean Journal of Physiology and Pharmacology
  40. RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer
    Derek J. Dustin, Guowei Gu, Amanda R. Beyer, Sarah K. Herzog, David G. Edwards, Hangqing Lin, Thomas L. Gonzalez, Sandra L. Grimm, Cristian Coarfa, Doug W. Chan et al. · 2020 · British Journal of Cancer
  41. Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays
    Pierre‐Marie Morice, Elodie Coquan, Louis‐Bastien Weiswald, Bernard Lambert, Dominique Vaur, Laurent Poulain · 2021 · British Journal of Cancer
  42. Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer
    Li-Ming Liu, Qiang Tang, Xin Hu, Jingjing Zhao, Yuan Zhang, Guoguang Ying, Fei Zhang · 2021 · Life
  43. Ultrastructural analysis of breast cancer patient-derived organoids
    Lorena Signati, Raffaele Allevi, F Piccotti, Sara Albasini, Laura Villani, Marta Sevieri, Arianna Bonizzi, Fabio Corsi, Serena Mazzucchelli · 2021 · Cancer Cell International
  44. Engineering mechanobiology through organoids‐on‐chip: A strategy to boost therapeutics
    Letícia Emiliano Charelli, João P. D. Ferreira, Carolina P. Naveira‐Cotta, Tiago Albertini Balbino · 2021 · Journal of Tissue Engineering and Regenerative Medicine
  45. Tumor organoids for cancer research and personalized medicine
    Hui Yang, Yinuo Wang, Peng Wang, Ning Zhang, Pengyuan Wang · 2021 · Cancer Biology and Medicine
  46. Synthetic developmental biology: Engineering approaches to guide multicellular organization
    Ibrahim Zarkesh, Mohammad Kazemi Ashtiani, Zahra Shiri, Saeideh Aran, Thomas W Braun, Hossein Baharvand · 2022 · Stem Cell Reports
  47. ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies
    Marion Perréard, Romane Florent, Jordane Divoux, Jean‐Michel Grellard, Justine Lequesne, Mélanie Briand, Bénédicte Clarisse, Nathalie Rousseau, Esther Lebreton, Brice Dubois et al. · 2023 · BMC Cancer
  48. Hallmark discoveries in the biology of Wilms tumour
    Daniela Perotti, Richard Dafydd Williams, Jenny Wegert, Jack J. Brzezinski, Mariana Camargo Maschietto, Sara Ciceri, David Gisselsson, Samantha Gadd, Amy L. Walz, Rhoikos Furtwängler et al. · 2023 · Nature Reviews Urology
  49. Cancer stem cell–immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet
    Aishwarya Guha, Kuntal Kanti Goswami, Jasmine Sultana, Nilanjan Ganguly, Pritha Roy Choudhury, Mohona Chakravarti, Avishek Bhuniya, Anirban Sarkar, Saurav Bera, Sukanya Dhar et al. · 2023 · Frontiers in Immunology
  50. Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma
    Jichuan Wang, Alexander Ferrena, Ranxin Zhang, Swapnil Singh, Valentina Viscarret, Waleed Al-Harden, Osama Aldahamsheh, Hasibagan Borjihan, Amit Kumar Singla, Simon Yaguare et al. · 2024 · Oncogene
  51. Emerging trends in modeling human liver disease in vitro
    Gregory H. Underhill, Salman R. Khetani · 2019 · APL Bioengineering
  52. Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
    Giandomenico Roviello, Giuseppe Aprile, Alberto D’Angelo, Luigi Francesco Iannone, Franco Roviello, Karol Połom, Enrico Mini, Martina Catalano · 2021 · Gastric Cancer
  53. In Situ Vitrification of Lung Cancer Organoids on a Microwell Array
    Qiang Liu, Tian Zhao, Xianning Wang, Zhongyao Chen, Yawei Hu, Xiaofang Chen · 2021 · Micromachines
  54. Recapitulating Tumorigenesis in vitro: Opportunities and Challenges of 3D Bioprinting
    Gabriela S. Kronemberger, Guilherme A. S. C. Miranda, Renata Spagolla Napoleão Tavares, B. Meira Montenegro, Úrsula de Almeida Kopke, Leandra Santos Baptista · 2021 · Frontiers in Bioengineering and Biotechnology
  55. Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
    Marco Calvinho Cavaco, Patrícia Fraga, Javier Valle, David Andreu, Miguel A. R. B. Castanho, Vera Neves · 2021 · Pharmaceutics
  56. Modeling the Role of Cancer-Associated Fibroblasts in Tumor Cell Invasion
    Stephanie Poon, Laurie Ailles · 2022 · Cancers
  57. The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
    Yaya Yu, Yan-juan Zhu, Zhenzhen Xiao, Yadong Chen, Xuesong Chang, Yi‐Hong Liu, Qing Tang, Haibo Zhang · 2022 · Biomarker Research
  58. Tumor Organoid and Spheroid Models for Cervical Cancer
    Ivana Kutle, Robert Polten, Jens Hachenberg, Rüdiger Klapdor, Michael Alexander Morgan, Axel Schambach · 2023 · Cancers
  59. Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer
    Yuting Tang, Ting Wang, Yaowen Hu, Hongli Ji, Botao Yan, Xiarong Hu, Yunli Zeng, Yifan Hao, Weisong Xue, Zexin Chen et al. · 2023 · iScience
  60. Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors
    Linlin Guo, Atish Ranjan Mohanty, Sharad S. Singhal, Saumya Srivastava, Arin Nam, Charles Warden, Sravani Keerthi Ramisetty, Yate‐Ching Yuan, Hyejin Cho, Xiwei Wu et al. · 2023 · iScience
  61. How to find the right drug for each patient? Advances and challenges in pharmacogenomics
    Angeliki Kalamara, Luis Tobalina, Julio Sáez-Rodríguez · 2018 · Current Opinion in Systems Biology
  62. Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development
    Anna Arnal Estape, Giorgia Foggetti, Jacqueline H. Starrett, Don X. Nguyen, Katerina A. Politi · 2021 · Cold Spring Harbor Perspectives in Medicine
  63. Organoids in skin wound healing
    Zitong Wang, Feng Zhao, Hongxin Lang, Haiyue Ren, Qiqi Zhang, Xing Huang, Cai He, Chengcheng Xu, Chiyu Tan, Jiajie Ma et al. · 2024 · Burns & Trauma
  64. Artificial Intelligence for Organoids Multidimensional Assessment
    Yulin Mo, Jian Wang, Huijian Yang, Long Bai, Ke Xu, Jiacan Su · 2025 · SmartMat
  65. Microfluidic device for expedited tumor growth towards drug evaluation
    Christopher George Uhl, Yaling Liu · 2019 · Lab on a Chip
  66. Parthenolide and its Analogues: A New Potential Strategy for the Treatment of Triple-Negative Breast Tumors
    Thaise Gonçalves Araújo, Lara Vecchi, Paula Marynella Alves Pereira Lima, Everton Allan Ferreira, Igor Moreira Campos, Douglas Cardoso Brandão, Gabriela Silva Guimarães, Matheus Alves Ribeiro, Ademar Alves da Silva Filho · 2019 · Current Medicinal Chemistry
  67. Pheno-seq – linking visual features and gene expression in 3D cell culture systems
    Stephan M. Tirier, Jeongbin Park, Friedrich Preußer, Lisa Amrhein, Zuguang Gu, Simon Steiger, Jan‐Philipp Mallm, Teresa G. Krieger, Marcel Waschow, Björn Eismann et al. · 2019 · Scientific Reports
  68. Patient-Derived Xenograft vs. Organoids: A Preliminary Analysis of Cancer Research Output, Funding and Human Health Impact in 2014–2019
    Lindsay J. Marshall, Marcia Triunfol, Troy Seidle · 2020 · Animals
  69. Breast cancer organoid model allowed to reveal potentially beneficial combinations of 3,3′-diindolylmethane and chemotherapy drugs
    Sergey V. Nikulin, B. Yа. Alekseev, Nataliya S. Sergeeva, Pavel A. Karalkin, Elizaveta K. Nezhurina, Valentina A. Kirsanova, Irina K. Sviridova, Suraja A. Akhmedova, Н. Н. Волченко, Л. В. Болотина et al. · 2020 · Biochimie
  70. Heterozygous APC germline mutations impart predisposition to colorectal cancer
    Livia Preisler, Aline Habib, Guy Shapira, Liron Kuznitsov-Yanovsky, Yoav Mayshar, Ilana Carmel-Gross, Mira Malcov, Foad Azem, Noam Shomron, Revital Kariv et al. · 2021 · Scientific Reports
  71. Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
    Jing-Wei Li, Kun Fang, L. Choppavarapu, Ke Yang, Yi-Ni Yang, Junbai Wang, Ruifeng Cao, I. Jatoi, Victor X. Jin · 2021 · Clinical Epigenetics
  72. Application Progress of Organoids in Colorectal Cancer
    Lianxiang Luo, Yucui Ma, Yilin Zheng, Jiating Su, Guoxin Huang · 2022 · Frontiers in Cell and Developmental Biology
  73. Growth factor dependency in mammary organoids regulates ductal morphogenesis during organ regeneration
    Sounak Sahu, Mary E. Albaugh, Betty K. Martin, Nimit L. Patel, Lisa A. Riffle, Susan Mackem, Joseph D. Kalen, Shyam K. Sharan · 2022 · Scientific Reports
  74. Next generation patient derived tumor organoids
    Enrique Podaza, Hui–Hsuan Kuo, John Nguyen, Olivier Elemento, M. Laura Martín · 2022 · Translational research
  75. Development and characterization of patient-derived salivary gland cancer organoid cultures
    Gerben Lassche, Wim van Boxtel, Tilly Wilhelmina Aalders, Onno van Hooij, Adriana C. H. van Engen–van Grunsven, Gerald W.C.T Verhaegh, Carla M.L. van Herpen, Jack A. Schalken · 2022 · Oral Oncology
  76. Multi-compartment tumor organoids
    Meng‐Horng Lee, Gabriella C. Russo, Yohan Suryo Rahmanto, Wenxuan Du, Ashleigh J. Crawford, Pei‐Hsun Wu, Daniele M. Gilkes, Ashley L. Kiemen, Tsutomu Miyamoto, Yu Yu et al. · 2020 · Materials Today
  77. Cancer organoid applications to investigate chemotherapy resistance
    Kenji Harada, Naoya Sakamoto · 2022 · Frontiers in Molecular Biosciences
  78. Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids
    Xian Lin, Dong Chen, Xinyu Chu · 2023 · Phytomedicine
  79. Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)
    Sang‐Yun Lee, Hyeong Jun Cho, Jimin Choi, Bosung Ku, Seok Whan Moon, Mi Hyoung Moon, Kyung Soo Kim, Kwanyong Hyun, Tae Jung Kim, Yeoun Eun Sung et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  80. Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine
    Josephine Amalia Taverna, Chia‐Nung Hung, Madison H. Williams, Ryan Williams, Meizhen Chen, Samaneh Kamali, Vaishnavi Sambandam, Cheryl Hsiang-Ling Chiu, Paweł A. Osmulski, Maria E. Gaczynska et al. · 2023 · Lung Cancer
  81. Inflammatory breast cancer: The pathologists' perspective
    Gábor Cserni, Emmanuelle Charafe‐Jauffret, P. J. van Diest · 2018 · European Journal of Surgical Oncology
  82. Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture
    Eiríkur Briem, Sævar Ingþórsson, Gunnhildur Ásta Traustadóttir · 2019 · Journal of Mammary Gland Biology and Neoplasia
  83. Organoid in colorectal cancer: progress and challenges
    Dengbo Ji, Aiwen Wu · 2020 · Chinese Medical Journal
  84. Patient-derived cancer organoid tracking with wide-field one-photon redox imaging to assess treatment response
    Daniel A. Gil, Dustin A. Deming, Melissa C. Skala · 2021 · Journal of Biomedical Optics
  85. The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
    Bae, JuneSung, Choi, Yun Sik, Cho, Gunsik, Jang, Se Jin · 2022 · Cancers
  86. Patient-derived tumor models and their distinctive applications in personalized drug therapy
    Jia He, Chunhe Zhang, Aliçan Özkan, Tang Feng, Peiyan Duan, Shuo Wang, Xinrui Yang, Jing Xie, Xiaoheng Liu · 2023 · Mechanobiology in Medicine
  87. Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
    Ximin Tan, Deguang Kong, Zhuoli Tao, Fangling Cheng, Baoyuan Zhang, Zaiqi Wang, Qi Mei, Chuang Chen, Kongming Wu · 2024 · Biomarker Research
  88. Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
    Maryam Arshad, Abul Azad, Phoebe Yuen Ka Chan, Vasanthy Vigneswara, Katharina Feldinger, Siti Norasikin Mohd Nafi, Eloise Laporte-Maguire, Carmela De Santo, Jianmin Zuo, Abeer M. Shaaban et al. · 2024 · British Journal of Cancer
  89. The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments
    Carolina Momoli, Beatrice Costa, Lorenzo Lenti, Matilde Tubertini, Marco Parenti, Elisa Martella, Greta Varchi, Claudia Ferroni · 2025 · Cancers
  90. Integration of Organoids With CRISPR Screens: A Narrative Review
    Rushikesh Mukhare, Khushboo Gandhi, Anushree Kadam, Aishwarya Raja, Ankita Singh, Mrudula Madhav, Rohan Chaubal, Shwetali Pandey, Sudeep Gupta · 2025 · Biology of the Cell
  91. In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?
    Giovanna Cassone Salata, Camila Megumi Hirokawa, Giovanna Barros de Melo, Isabella D. Malagó, Jessica Ribeiro Nunes, Julia Sapienza Passos, Regina G. Daré, Luciana B. Lopes · 2025 · Cancer Nanotechnology
  92. Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives
    Floriana Jessica Di Paola, Giulia Calafato, Pier Paolo Piccaluga, Giovanni Tallini, Kerry Jane Rhoden · 2025 · Journal of Personalized Medicine
  93. Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug‐Resistant Model and Genome‐Wide siRNA Screening
    Fangyuan Shao, Xueying Lyu, Kai Miao, Lisi Xie, Haitao Wang, Hao Xiao, Jie Li, Qiang Chen, Ren‐Bo Ding, Ping Chen et al. · 2020 · Advanced Science
  94. Systems Biology and Experimental Model Systems of Cancer
    Gizem Damla Yalçın, Nurseda Danisik, Rana Can Baygin, Ahmet Acar · 2020 · Journal of Personalized Medicine
  95. The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids
    Sarah Line Bring Truelsen, Nabi Mousavi, Haoche Wei, Lucy Harvey, Rikke Stausholm, Erik Spillum, Grith Hagel, Klaus Qvortrup, Maria Thastrup, Henrik Harling et al. · 2021 · PLoS ONE
  96. Models for Translational Proton Radiobiology—From Bench to Bedside and Back
    Theresa Suckert, Sindi Nexhipi, Antje Dietrich, Robin A Koch, Leoni A. Kunz‐Schughart, Emanuel Bahn, Elke Beyreuther · 2021 · Cancers
  97. Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin
    Stefan Richard Bornstein, Igor Shapiro, Maria Malyukov, Richard Züllig, Edlira Luca, Evgeny Gelfgat, Felix Beuschlein, Svenja Nölting, Alfredo Berruti, Sandra Sigala et al. · 2022 · Cell Death and Disease
  98. Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research
    Steven Donald Forsythe, Richard A. Erali, Preston Laney, Hemamylammal Sivakumar, Wencheng Li, Aleksander Skardal, Shay Söker, Konstantinos Ioannis Votanopoulos · 2022 · Scientific Reports
  99. Genomic and Epigenomic Characterization of Tumor Organoid Models
    Chehyun Nam, Benjamin Ziman, Megha Sheth, Hua Zhao, De‐Chen Lin · 2022 · Cancers
  100. Roadmap on biomaterials for women’s health
    Kaitlin C. Fogg, Ning-Hsuan Tseng, Shelly R. Peyton, William Pieper Holeman, Shannon T. McLoughlin, John P. Fisher, Allison Sutton, Ariella Shikanov, Juan S. Gnecco, Katrina M. Knight et al. · 2022 · Journal of Physics Materials